Univest
Univest
  • Markets

Dhampur Bio Organics Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target

  • July 9, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Dhampur Bio Organics Q1 Results FY27

Dhampur Bio Organics CMP Rs.112. Q1 FY27E revenue Rs.811-933 Cr. PAT estimate Rs.-20–25 Cr. 12-month target Rs.119-134.

Dhampur Bio Organics Q1 Results FY27 is coming into focus as investors position ahead of the July-August 2026 results season, with Dhampur Bio Organics shares trading at Rs.112 against a market capitalisation of Rs.763 Cr and a price-to-earnings multiple of Not meaningful. As a FMCG name on the NSE and BSE, Dhampur Bio Organics enters the Dhampur Bio Organics Q1 Results FY27 print with the Street watching revenue momentum, margin trajectory and management commentary on FY27 guidance.

This Dhampur Bio Organics Q1 Results FY27 preview is built on a trailing-growth framework applied to the company’s Q1 FY26 base of Rs.785 Cr revenue and Rs.-22 Cr net profit, using the most recent year-on-year growth signal from Q4 FY26. This Q1 prediction is a Uniresearch trailing-growth projection, not a formal analyst estimate, and should be read alongside the company’s own guidance once released.

Get Free Investment Predictions and Dhampur Bio Organics Research at Univest

Table of Contents

Toggle
  • About Dhampur Bio Organics
  • Dhampur Bio Organics Q1 FY27 Estimates
  • Key Catalysts to Watch
    • 1. Rural Demand Recovery
    • 2. Input Cost Moderation
    • 3. Distribution Expansion
  • Key Risks to the Dhampur Bio Organics Q1 Results FY27 Outlook
  • Q4 FY26 Performance Context for the Dhampur Bio Organics Q1 Results FY27 Print
  • Technical Analysis Ahead of Dhampur Bio Organics Q1 Results FY27
  • Share Price Target Based on the Dhampur Bio Organics Q1 Results FY27 Outlook
    • 3-6 Month Target
    • 12-Month Target
    • FY27-28 Outlook
  • What to Watch in the Dhampur Bio Organics Q1 Results FY27 Print
  • Conclusion on Dhampur Bio Organics Q1 Results FY27
  • FAQs on Dhampur Bio Organics Q1 Results FY27
    • When are Dhampur Bio Organics Q1 FY27 results expected?
    • What is the Dhampur Bio Organics Q1 FY27 revenue estimate?
    • What is the Dhampur Bio Organics share price target?
    • Is Dhampur Bio Organics a good buy before Q1 FY27 results?
    • What should investors watch in Dhampur Bio Organics’s Q1 FY27 results?
    • Where can I track Dhampur Bio Organics share price live?

About Dhampur Bio Organics

Dhampur Bio Organics (NSE: DBOL) operates in the FMCG space and is tracked on Univest under its NSE and BSE listings. Ahead of the Dhampur Bio Organics Q1 Results FY27 print, the company’s most recent reported quarter (Q4 FY26) shows revenue of Rs.781 Cr and net profit of Rs.46 Cr, forming the base against which the Dhampur Bio Organics Q1 Results FY27 estimates in this article are built. This Dhampur Bio Organics Q1 Results FY27 snapshot is intended as a starting point for research, not a substitute for the company’s own disclosures.

Dhampur Bio Organics Q1 FY27 Estimates

Metric Q1 FY27E (Range) Q1 FY26 Actual YoY Growth
Revenue (Rs. Cr) 811-933 785 +11.0%
Net Profit / PAT (Rs. Cr) -20–25 -22 +3.3%
Results Date July-August 2026 (indicative)
12-Month Target (Uniresearch Estimate) Rs.119-134

Univest, a SEBI-Registered Investment Advisor, Tracks Dhampur Bio Organics Ahead of Q1 FY27 Results

Key Catalysts to Watch

1. Rural Demand Recovery

Rural demand recovery and price hikes supporting revenue growth for the quarter is one of the primary variables that analysts are tracking ahead of Dhampur Bio Organics’s Q1 FY27 results and FY27 guidance. The market’s reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the Dhampur Bio Organics share price target or faces renewed pressure.

2. Input Cost Moderation

Input cost moderation aiding gross margin versus the year-ago period is one of the primary variables that analysts are tracking ahead of Dhampur Bio Organics’s Q1 FY27 results and FY27 guidance. The market’s reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the Dhampur Bio Organics share price target or faces renewed pressure.

3. Distribution Expansion

Distribution expansion and new launches widening the portfolio reach is one of the primary variables that analysts are tracking ahead of Dhampur Bio Organics’s Q1 FY27 results and FY27 guidance. The market’s reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the Dhampur Bio Organics share price target or faces renewed pressure.

Download the Univest iOS App or Univest Android App to track Dhampur Bio Organics’s live price and Q1 FY27 result updates.

Key Risks to the Dhampur Bio Organics Q1 Results FY27 Outlook

  • Input cost inflation in key raw materials pressuring gross margin.
  • Slower rural demand recovery affecting volume growth.
  • Intensifying competition from regional and unorganised players.

Q4 FY26 Performance Context for the Dhampur Bio Organics Q1 Results FY27 Print

Dhampur Bio Organics closed Q4 FY26 with revenue of Rs.781 Cr and net profit of Rs.46 Cr, a year-on-year revenue change of +11.0% and PAT change of +3.3% versus Q4 FY25. This base underpins the Dhampur Bio Organics Q1 Results FY27 projection used in this preview and should be read alongside the company’s own Dhampur Bio Organics Q1 Results FY27 commentary once reported.

Technical Analysis Ahead of Dhampur Bio Organics Q1 Results FY27

Dhampur Bio Organics shares last traded at Rs.112. For the current 52-week high and low, support and resistance levels, investors should check the live chart on the Univest app or the NSE website, since these levels move intraday and are not reproduced here to avoid stale data.

Share Price Target Based on the Dhampur Bio Organics Q1 Results FY27 Outlook

3-6 Month Target

Over a 3-6 month horizon, the Dhampur Bio Organics Q1 Results FY27 trailing-growth framework points to a range of Rs.112-121 for Dhampur Bio Organics, contingent on the Dhampur Bio Organics Q1 Results FY27 print matching or beating the trailing growth trend.

12-Month Target

The 12-month target (Uniresearch estimate) tied to this Dhampur Bio Organics Q1 Results FY27 view for Dhampur Bio Organics works out to Rs.119-134, built on the same trailing revenue growth trend and current valuation multiple. Tracking is how Univest research categorises the stock heading into Dhampur Bio Organics Q1 Results FY27, not a formal Buy or Sell call.

FY27-28 Outlook

Looking out to FY27-28, a sustained continuation of the growth trajectory implied by this Dhampur Bio Organics Q1 Results FY27 analysis would put Dhampur Bio Organics in a Rs.129-149 range, though this is sensitive to sector-wide demand, cost trends and any change in the company’s competitive position.

What to Watch in the Dhampur Bio Organics Q1 Results FY27 Print

  • Revenue and PAT versus the Dhampur Bio Organics Q1 Results FY27 estimate range in this preview.
  • Management commentary on FY27 growth guidance and margin trajectory relevant to the Dhampur Bio Organics Q1 Results FY27 narrative.
  • Rural demand recovery and price hikes supporting revenue growth for the quarter
  • Input cost inflation in key raw materials pressuring gross margin

Conclusion on Dhampur Bio Organics Q1 Results FY27

Dhampur Bio Organics enters the Q1 FY27 results season trading at Rs.112, with the 12-month Uniresearch target range of Rs.119-134 reflecting a tracking stance. Investors tracking the Dhampur Bio Organics Q1 Results FY27 print should watch the catalysts and risks above and consult a SEBI-registered advisor before making investment decisions around the results.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs on Dhampur Bio Organics Q1 Results FY27

When are Dhampur Bio Organics Q1 FY27 results expected?

Ans. Dhampur Bio Organics’s Q1 FY27 results are expected in the July-August 2026 window, in line with the broader NSE and BSE results season for the quarter ending June 2026.

What is the Dhampur Bio Organics Q1 FY27 revenue estimate?

Ans. The Uniresearch trailing-growth estimate for Dhampur Bio Organics’s Q1 FY27 revenue is Rs.811-933 Cr, based on the Q1 FY26 base of Rs.785 Cr.

What is the Dhampur Bio Organics share price target?

Ans. The 12-month Uniresearch estimate for Dhampur Bio Organics share price target is Rs.119-134, based on trailing growth and current valuation multiples.

Is Dhampur Bio Organics a good buy before Q1 FY27 results?

Ans. Dhampur Bio Organics is tracking heading into Q1 FY27 results. Investors should weigh the catalysts and risks in this article and consult a SEBI-registered advisor before investing.

What should investors watch in Dhampur Bio Organics’s Q1 FY27 results?

Ans. Key items include revenue and PAT versus estimates, management commentary on FY27 guidance, and rural demand recovery and price hikes supporting revenue growth for the quarter.

Where can I track Dhampur Bio Organics share price live?

Ans. Dhampur Bio Organics share price can be tracked live on the Univest app and website, along with research updates from SEBI-registered analysts.



News
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply